3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Prostatic Neoplasms
4
Neoplasms
3
Sarcoma
2
Lymphoma, Follicular
2
Lymphoma
2
Glioblastoma
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Thrombosis
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor, Adult
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumothorax
1
Pituitary Neoplasms
1
Philadelphia Chromosome
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Opioid-Related Disorders
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Metastatic Castration-resistant Prostate Cancer
1
Meningioma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
Magnetic Resonance Spectroscopy
4
Temozolomide
3
Surgical Procedures, Operative
3
trametinib
2
Magnetic Resonance Imaging
2
Irinotecan
2
Bortezomib
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
temsirolimus
1
sonidegib
1
ribociclib
1
gallium Ga 68 dotatate
1
fluoromisonidazole
1
entinostat
1
emvododstat
1
carboxyamido-triazole
1
avelumab
1
aldesleukin
1
Vorinostat
1
Verteporfin
1
Topotecan
1
Thalidomide
1
Surveys and Questionnaires
1
Sodium Chloride
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiosurgery
1
Proton Therapy
1
Pioglitazone
1
Photochemotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Meningioma
×
Blood Specimen Collection
×
Clear all
NCT03631953
2024-08-06
ALTREM
Assistance Publique Hopitaux De Marseille
Phase 1
Recruiting
25 enrolled